0001209191-23-016714.txt : 20230307 0001209191-23-016714.hdr.sgml : 20230307 20230307161141 ACCESSION NUMBER: 0001209191-23-016714 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230303 FILED AS OF DATE: 20230307 DATE AS OF CHANGE: 20230307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sabag Mark CENTRAL INDEX KEY: 0001721442 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16174 FILM NUMBER: 23712716 MAIL ADDRESS: STREET 1: 5 BASEL STREET, P.O. BOX 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 4951033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD CENTRAL INDEX KEY: 0000818686 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 BAZEL ST STREET 2: P O B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 BUSINESS PHONE: 9729267267 MAIL ADDRESS: STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED STREET 2: 5 BAZEL ST PO B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-03 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001721442 Sabag Mark C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST., TEL AVIV L3 6944020 ISRAEL 0 1 0 0 EVP, International Markets Ordinary Shares 2023-03-04 4 M 0 33512 A 281997 D Ordinary Shares 2023-03-04 4 M 0 15921 A 297918 D Ordinary Shares 2023-03-05 4 M 0 23764 A 321682 D Restricted Share Units 2023-03-03 4 A 0 99601 0.00 A Ordinary Shares 99601 99601 D Restricted Share Units 2023-03-04 4 M 0 15921 0.00 D Ordinary Shares 15921 0 D Restricted Share Units 2023-03-04 4 M 0 33512 0.00 D Ordinary Shares 33512 100536 D Restricted Share Units 2023-03-05 4 M 0 23764 0.00 D Ordinary Shares 23764 47529 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027. Restricted share units were granted on March 4, 2019, with 15,920 vested on each of March 4, 2021 and March 4, 2022, and 15,921 vested on March 4, 2023. Restricted share units were granted on March 4, 2022, with 33,512 vested on March 4, 2023, and 33,512 vesting on each of March 4, 2024, March 4, 2025 and March 4, 2026. Restricted share units were granted on March 5, 2021, with 23,764 vested on each of March 5, 2022 and March 5, 2023, 23,764 vesting on March 5, 2024, and 23,765 vesting on March 5, 2025. /s/ Dov Bergwerk as attorney-in-fact for Mark Sabag 2023-03-07